Related Experiment Video
Updated: Jun 15, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Glycaemic status influences the nature and severity of coronary artery disease
C Berry1, S Noble, J C Grégoire
1Montreal Heart Institute and Université de Montréal, 5000 Belanger Street, Montreal, QC H1T 1C8, Canada.
Insights
Higher fasting blood glucose and HbA1c levels correlate with increased coronary artery disease (CAD) severity and progression. Better glycemic control may benefit patients with diabetes or impaired glucose tolerance.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Metabolic Syndrome
Background:
- Coronary artery disease (CAD) is a leading cause of mortality, particularly in individuals with diabetes.
- Glycaemic status significantly impacts cardiovascular health, necessitating research into its specific effects on CAD.
- Understanding the link between glucose metabolism and atherosclerosis is crucial for preventative strategies.
Purpose of the Study:
- To investigate the association between glycaemic status (normoglycaemia, impaired fasting glucose, diabetes) and the severity of coronary artery disease (CAD).
- To determine the relationship between glycaemic status and the progression of CAD over time.
- To explore the correlation between fasting blood glucose (FBG) and HbA1c levels with measures of coronary atherosclerosis.
Main Methods:
- A cohort of 426 patients with stable CAD underwent intravascular ultrasound (IVUS) at baseline and follow-up (mean 664 days).
- Fasting blood glucose (FBG) and HbA1c were measured at baseline.
- Patients were categorized into normoglycaemic, impaired fasting glucose, and diabetic groups.
Main Results:
- Diabetic patients exhibited greater baseline coronary atheroma area compared to normoglycaemic and impaired fasting glucose groups (p<0.001).
- Progression of atheroma area during follow-up was significantly higher in diabetic patients (1.86%) versus others (0.28-0.56%, p=0.0047).
- Both FBG and HbA1c correlated significantly with baseline atheroma area and plaque volume, with HbA1c also correlating with plaque area change.
Conclusions:
- Elevated fasting blood glucose, HbA1c, and the presence of diabetes are independently associated with increased coronary atherosclerosis severity and progression.
- These findings suggest that improved glycemic control could be a key factor in mitigating CAD progression in at-risk populations.
- The study underscores the importance of managing glucose metabolism for cardiovascular health in patients with or at risk for diabetes.
Aims/Hypothesis:
We sought to understand the relationships between glycaemic status and both severity and progression of coronary artery disease (CAD), the leading cause of death in diabetes.
Methods:
Baseline fasting blood glucose (FBG) and HbA1c (%)were measured in 426 patients with known or suspected stable CAD, who underwent coronary artery intravascular ultrasound(IVUS) at baseline and after a mean follow-up period of 664 days (range 257 to 961). The patients were categorised as normoglycaemic (n=226, 53%), or as having impaired fasting glucose (n=118, 28%) or diabetes (n=82, 19%).
Results:
The maximum percentage coronary atheroma area at baseline was greater in diabetic patients (73.33+/-8.86%) than in those with normoglycaemia (69.08+/-10.43%; p=0.001) and impaired fasting glucose (69.32+/-9.59%; p=0.0031). In averaged IVUS measurements of the 30-mm target segment(n=332 participants), change in percentage atheroma area during follow-up was also greater in the diabetes (1.86+/-3.90%) than in other groups (0.28+/-3.32% and 0.56+/-2.96%,p=0.0047 global). FBG correlated with maximum percentage atheroma area at baseline (r=0.17; p=0.0003). HbA1c also correlated with maximum percentage atheroma area at baseline (r=0.26; p=0.0001) and with change in maximum plaque area (r=0.16; p=0.016). A similar pattern of results occurred with plaque volume. The relationships between diabetes or HbA1c and both IVUS measurements of plaque burden and remodelling persisted after adjustment.
Conclusions/Interpretation:
Fasting blood glucose, HbA1c and the presence of diabetes are associated with the severity and progression of coronary atherosclerosis. These observations support the hypothesis that better glycaemic control may favourably influence CAD in patients with abnormal glucose tolerance or diabetes.
Related Concept Videos
Coronary Artery Disease I: Introduction
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Coronary Artery Disease II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Hyperglycemia
Coronary Artery Disease IV: Preventive Measures